Clorox (CLX) FY2013 results: revenue $5.5 billion, up 2.9% on the year
Clorox Co. (CLX) reported revenue of $5.5 billion for fiscal 2013, the year ended 30 June 2013, up 2.9% on the year before. Net income was $572 million, up 5.7%, and diluted earnings per share $4.30. The figures are the company's own, from the 10-K it filed with the SEC on 23 August 2013.
Revenue
$5.5 billion
+2.9% on the year
FY2008FY2013
Operating margin
n/a
FY2008FY2013
Net income
$572 million
+5.7% on the year
FY2008FY2013
Diluted EPS
$4.30
+5.1% on the year
FY2008FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
5,533
5,379
5,231
+2.9%
Cost of revenue
3,142
3,107
2,958
+1.1%
Gross profit
2,391
2,272
2,273
+5.2%
Gross margin
43.2%
42.2%
43.5%
Research and development
130
121
115
+7.4%
Selling, general and administrative
793
783
735
+1.3%
Interest expense
122
125
123
-2.4%
Income tax
279
243
276
+14.8%
Net income
572
541
557
+5.7%
Net margin
10.3%
10.1%
10.6%
Diluted EPS
$4.30
$4.09
$4.02
+5.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
775
612
698
+26.6%
Capital expenditure
190
189
228
+0.5%
Free cash flow
585
423
470
+38.3%
Free cash flow margin
10.6%
7.9%
9.0%
Cash from investing
-55.0
-277
544
Cash from financing
-685
-321
-1,078
Depreciation and amortisation
182
178
173
+2.2%
Share-based compensation
35.0
27.0
32.0
+29.6%
Buybacks
128
225
655
-43.1%
Dividends paid
335
315
303
+6.3%
Dividend per share
$2.63
$2.44
$2.25
+7.8%
Diluted shares, weighted
133m
132m
138m
+0.5%
Shares outstanding at period end
130m
130m
131m
+0.6%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
146
-135
-86.0
Debt
2,372
2,721
2,584
-12.8%
Other liabilities
1,784
1,769
1,665
+0.8%
Total liabilities and equity
4,302
4,355
4,163
-1.2%
Fixed assets
1,021
1,081
1,039
-5.6%
Goodwill
1,105
1,112
1,070
-0.6%
Cash and equivalents
299
267
259
+12.0%
Receivables
580
576
525
+0.7%
Inventory
394
384
382
+2.6%
Other assets
903
935
888
-3.4%
Total assets
4,302
4,355
4,163
-1.2%
10-K for the year ended 30 June 2013, filed 23 August 2013: the filing.